Blending Treatments Worldwide for Multiple Myeloma

David S. Siegel, MD, PhD

Video Categories: Hematological Malignancies

David S. Siegel, MD, PhD, at the John Theurer Cancer Center in Hackensack, NJ, explains the benefits of worldwide clinical trials in creating more consistent, less toxic treatment options for multiple myeloma. New drugs are coming along, and the clinical trials for those drugs are beginning to mature.

Related Videos

January 20, 2016

Which Part of Stem Cells Should Be Treated?

Dr Wainberg and Dr Gerson discuss the ongoing debate about whether clinicians should treat the surface or the internal structure of cancer stem cells.

September 20, 2013

Value Proposition of Personalized Medicine

John Hennessy discusses the benefits of the “personalized medicine toolkit” to help make better decisions